BioPharma Drug Discovery
Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology
This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transfo...
June 30, 2023 | News
Harbour BioMed's Batoclimab Receives NMPA Acceptance for Generalized Myasthenia Gravis Treatment
"Anti-FcRn treatment is at the center of focus in gMG disease area. Batoclimab is the first anti-FcRn treatment completed clinical development with po...
June 30, 2023 | News
Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D
This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...
June 29, 2023 | News
Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment
Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...
June 29, 2023 | News
AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine
After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...
June 28, 2023 | News
HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.
OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...
June 27, 2023 | News
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharmaceuticals to Develop a Novel Cancer Therapeutic
The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton). The licen...
June 23, 2023 | News
Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress
The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...
June 21, 2023 | News
Jadeite Medicines Granted Orphan Drug Designation and Initiates Phase 3 Trial for Odevixibat in PFIC by Japanese Ministry of Health
This Phase 3 trial will evaluate the efficacy and safety of an oral dosage of odevixibat in Japanese PFIC patients. Odevixibat is marketed by Ipsen Pharma ...
June 21, 2023 | News
AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement
This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...
June 19, 2023 | News
PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio Agreement to utilize PrecisionLife’s combi...
June 16, 2023 | News
C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API
C2 Pharma the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the appro...
June 14, 2023 | News
Biostar Pharma Enrolls First Patient for Phase 1 Study of UTD2, World's First Oral Epothilone Anti-Cancer Drug
This study will be conducted at multiple clinical research centers including Sarah Cannon Research Institute (Florida Cancer Specialists & Research Ins...
June 13, 2023 | News
LTS Expands into Large Molecule Drug Delivery with Sorrel Wearable Injection Device Acquisition
The acquisition of Sorrel is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms. Sorrel's large volume wearable injector t...
June 09, 2023 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
